Home >

Top Features



Mar 12, 2021
“Data on cancer prevalence and outcomes for transgender people are urgently needed to understand and intervene in disparities,” said lead author Dr. Ash B. Alpert
Mar 08, 2021
First YIA recipient Dr. Judith Kaur looks to the future with Conquer Cancer Board chair Dr. Howard A. “Skip” Burris III.

Exclusive Journals Coverage

Nov 16, 2020
In a special two-part series of articles published in JCO Global Oncology (JCO GO), experts take a closer look at oncology care and research in Africa. 
Jun 03, 2020
As oncologists evaluate early research on on COVID-19 and cancer care, Dr. Stephen A. Cannistra notes, the data and conclusions should be interpreted with caution at this stage.

Current Controversies in Oncology

Jul 17, 2018
The era of precision medicine in oncology offers promise for improved diagnosis and better therapy for patients with the CUP syndrome, and first steps have already been taken toward incorporating precision medicine into the routine management of disease in these patients. 
Apr 25, 2018
Drs. Sarah W. Gordon, Sarah M. Temkin, Debra L. Richardson, and Kathleen Moore debate the role of maintenance PARP in platinum-sensitive ovarian cancer.

ASCO International

Apr 06, 2021
Council members will serve as voices for their respective countries, facilitate engagement in ASCO’s global programs, and work with Society leadership and staff to tailor ASCO programs to best support members in the region.
Mar 09, 2021
As with everything else in 2020, the IDEA experience did not proceed in the typical fashion this year, and ASCO’s International Affairs team had to quickly create a virtual curriculum that would offer the same level of valuable learning and mentorship that would normally occur.

Trainee & Early-Career Oncologists

Mar 08, 2021
Dr. Ogie M. Ezeoke is a categorical pediatric PGY-2 at the Ann & Robert H. Lurie Children’s Hospital of Chicago. “I feel I must have fallen in love with the city, coming to the ASCO Annual Meeting every year but one, starting from 2013!” she said. 
Mar 04, 2021
Dr. Sherilyn Tuazon is innovating new approaches to autologous stem cell transplant (ASCT) treatment for patients with multiple myeloma.